The deal would help accelerate growth in J&J's drugs business after the company spun off its consumer health unit in 2023. It has made several transactions in the past few years to boost its ...
J&J's $132 per-share offer implies 39% premium Deal could kick off spree of activity in sector in 2025 CEO says such large deals not common The deal would help accelerate growth in J&J's drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback